Dr. Elliot Martin Kaufman, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 154 Duchess Ave, Newport, VT 05855 Phone: 802-334-6744 Fax: 802-334-7450 |
Gian Paolo Bentivoglio, MD Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 154 Duchess Ave, Northeast Kingdom Human Services, Newport, VT 05855 Phone: 802-334-6744 Fax: 802-334-7340 |
Dr. Richard D Edelstein, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 154 Duchess Street, Newport, VT 05855 Phone: 802-334-6744 Fax: 802-334-7450 |
Dr. Rizwan Ul Haq, MD Psychiatry & Neurology - Clinical Neurophysiology Medicare: Accepting Medicare Assignments Practice Location: 41 Medical Village Dr, Newport, VT 05855 Phone: 802-334-3500 |
News Archive
CareFusion, a BD company, will be displaying new respiratory solutions that are designed to put patients first, whether ventilated or breathing on their own, at the American Association for Respiratory Care Congress being held Nov. 7-10 in Tampa, Fla.
USA Today: Sen. Jim DeMint — along with a dozen Republican co-sponsors — introduced legislation to repeal the health care reform law. "We must repeal this bill and start over.
The rapid development of a safe and effective vaccine to prevent the Zika virus (ZIKV) is a global priority, as infection in pregnant women has been shown to lead to fetal microcephaly and other major birth defects.
Young children who consume substantial amounts of fluoride through infant formula and other beverages mixed with fluoridated water or by swallowing fluoride toothpaste have an increased chance of developing mild enamel fluorosis, according to research published in the October issue of The Journal of the American Dental Association and supported by the National Institute of Dental and Craniofacial Research.
Arcturus Therapeutics Holdings Inc., a leading clinical-stage messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare diseases and vaccines, and Duke-NUS Medical School, Singapore's flagship research-intensive graduate entry medical school, today announced that the Clinical Trial Application for COVID-19 vaccine candidate LUNAR-COV19 has been approved to proceed by the Singapore Health Sciences Authority.
› Verified 5 days ago